Solara Active Pharma Sciences declares Q1 FY27 unaudited results

Solara Active Pharma Sciences Limited announced that its Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were approved during a board meeting held on July 23, 2026. The company has submitted these results along with the Limited Review Report from its statutory auditors, Deloitte Haskins & Sells LLP. The financial results will also be made available on the company's investor relations website. The board meeting commenced at 12:00 PM and concluded at 1:05 PM.